Risk perception and communication in sub-saharan Africa

Drug Safety

Volumn 35, Issue 11, 2012, Pages 1041-1052

  Dodoo, Alexander ^a   Hugman, Bruce ^b,c  

^a UNIVERSITY OF GHANA   (Ghana)

^b UPPSALA MONITORING CENTRE   (Sweden)

^c NONE

Author keywords

Health care services; Risk communication.

Indexed keywords

ALBENDAZOLE; AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE PLUS PYRONARIDINE; CHLORPROGUANIL PLUS DAPSONE; DIHYDROARTEMISININ PLUS PIPERAQUINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEBENDAZOLE; PERTUSSIS VACCINE; PRAZIQUANTEL;

AFRICA; COMPREHENSION; CULTURAL FACTOR; DRUG APPROVAL; DRUG FATALITY; DRUG FORMULATION; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DYSTONIA; EDUCATION; ETHNICITY; GHANA; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HUMAN; MALARIA; MALAWI; MONITORING; MUSCLE WEAKNESS; NIGERIA; PATIENT SAFETY; PERCEPTION; PRIORITY JOURNAL; RELIGION; REVIEW; RISK COMMUNICATION; RISK MANAGEMENT; RISK PERCEPTION; SCHISTOSOMIASIS; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT;

AFRICA SOUTH OF THE SAHARA; COMMUNICATION; DEVELOPING COUNTRIES; DRUG INDUSTRY; DRUG TOXICITY; HEALTH PERSONNEL; HUMANS; PATIENT MEDICATION KNOWLEDGE; PHARMACEUTICAL PREPARATIONS; PHARMACOVIGILANCE; RISK; RISK MANAGEMENT;

EID: 84867537129     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11636270-000000000-00000     Document Type: Review

References (65)

1. Ted C, Schroeder TC, Glynn T, et al. The role of consumer risk perceptions and attitudes in cross cultural beef consumption changes. Selected paper prepared for presentation at the Western Agricultural Economics Association Annual Meeting; 2007 Jul 29-Aug 1; Portland (OR) 2.
2. Starr C. Social benefits versus technological risks. Science 1969 Sep 19; 165 (3899): 1232-8
3. Slovic P, Fischhoff B, Lichtenstein S. Why study risk perception? Risk Anal 1982; 2 (2): 83-93
4. Kasperson RE, Renn O, Slovic P, et al. The social amplification of risk: a conceptual framework. Risk Anal 1988; 8 (2): 177-87
5. Katafiasz AR, Bartlett P. Motivation for unpasteurized milk consumption in Michigan, 2011. Food Prot Trends 2012 Mar; 32 (3): 124-8
6. Public concerns regarding safety and efficacy of medicines; East and Central African J Pharm Sci 2008; 11 (2) [editorial; online]. Available from URL: http://www.uonbi.ac.ke/projects/ecajournal/index.php?option=com-docmantask= cat-viewgid=54Itemid=27limitstart=5 [Accessed 2012 Sep 18]
7. Frewer L. The public and effective risk communication. Toxicol Lett 2004 Apr 1; 149 (1-3): 391-7
8. Delgado M. Family win 18 year fight overMMR damage to son: d90,000 payout is first since concerns over vaccine surfaced; MailOnline 2010 Aug 28 [online]. Available from URL: http://www.dailymail.co.uk/news/article-1307095/Family-win- 18-year-fight-MMR-damage-son-90-000-pay out-concerns-vaccine-surfaced. html#ixzz23Ikz8RY3 [Accessed 2012 Sep 11]
9. Maugh TH. U.S. suffering worst whooping cough outbreak since 1959, CDC says. Los Angeles Times 2012 Jul 19 [online]. Available from URL: http://articles.latimes.com/2012/jul/19/science/la-sci-sn-pertussis-outbreak- 20120719 [Accessed 2012 Sep 11]
10. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoidnodular hyperplasia, non-specific colitis, and pervasivedevelopmental disorder in children [article formally retracted by The Lancet, February 2010]. Lancet 1998; 351: 637-41
11. Deer B. The Lancet scandal [www.briandeer.com; author of the influential investigation]. Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Health. MMR/Measles vaccine [online]. Available from URL: http://www. vaccinesafety.edu/cc-mmr.htm [Accessed 2012 Sep 11]
12. Lancet retracts Wakefield's MMR paper. BMJ 2010; 340: c696
13. Gorski D. Measles outbreaks, 2011. Science-Based Medicine [online]. Available from URL: http://www.sciencebased medicine.org/index.php/measles- outbreaks-2011/[Accessed 2012 Sep 11]
14. Ghayur MN. Pharmacy education in developing countries: need for a change. (This intelligent and critical letter also has a long list of useful references in this area.) Am J Pharm Educ 2008 Aug 15; 72 (4): 94
15. Dean C. Survey shows gap between scientists and the public. The New York Times 2009 Jul 9 [online]. Available from URL: http://www.nytimes.com/2009/07/ 10/science/10survey.html [Accessed 2012 Sep 11]
16. Durant J, Evans G, Thomas G. Public understanding of science in Britain: the role of medicine in the popular representation of science. Public Underst Sci 1992 Apr; 1 (2): 161-82 [online]. Available from URL: http://pus.sagepub. com/content/1/2/161 [Accessed 2012 Sep 11]
17. Debas HT, Laxminarayan R, Straus SE. Complementary and alternative medicine. Chapter 69. In: Jamison DT, Breman JG, Measham AR, et al., editors. Disease control priorities in developing countries. 2nd ed. Washington, DC: World Bank, 2006
18. Kapp C. Nigerian states again boycott polio-vaccination drive. Lancet 2004 Feb 28; 363 (9410): 709
19. Jegede AS. What led to the Nigerian boycott of the polio vaccination campaign? PLoS Med 2007 Mar; 4 (3): e73
20. Boseley S. Polio eradication at risk, warns report. The Guardian 2012 Jun 20 [online]. Available from URL: http://www.guardian.co.uk/world/2012/jun/20/ polio-eradication-atrisk [Accessed 2012 Sep 11]
21. Dodoo A, Adjei S, Couper M, et al. When rumours derail a mass deworming exercise. Lancet 2007 Aug 11; 370 (9586): 465-6
22. Pincock S. Poliovirus spreads beyond Nigeria after vaccine uptake drops. BMJ 2004 Feb 7; 328 (7435): 310
23. Okafor J-L. Nigeria: refusal of polio vaccine persists. All Africa 2012 Feb 21 [online]. Available from URL: allafrica. com/stories/201202211368.html [Accessed 2012 Sep 11]
24. Ogus A. Towards appropriate institutional arrangements for regulation in less developed countries [online]. Available from URL: www.competition- regulation.org.uk/con ferences/mcr05/ogus.pdf [Accessed 2012 Sep 11]
25. Luzzatto L. The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics. Lancet 2010 Aug 28; 376 (9742): 739-41
26. Oricha BS, Yauri MB. Dipyrone (Novalgin, Metamizole): banned and unbanned. The dilemma of a commonly prescribed and over the counter analgesic. Ann Afr Med 2003; 2 (2): 101-2 [online]. Available from URL: www.bioline. org.br/pdf?am03023 [Accessed 2012 Sep 11]
27. Musisi S, Musisi N. The legacies of colonialism in African medicine [online]. Available from URL: www.who.int/global-health-histories/seminars/ nairobi02.pdf [Accessed 2012 Sep 11]
28. Medicinal drugs in the third world. Cultural survival 2010 Feb 11 [online]. Available from URL: http://www.cultural survival.org/publications/ cultural-survival-quarterly/brazil/medicinal-drugs-third-world [Accessed 2012 Sep 11]
29. Registering drugs: the African context. DNDi and The George Institute for International Health, January 2012 [online]. Available from URL: www.scribd.com [Accessed 2012 Sep 11]
30. European Medicines Agency. EPAR summary for the public: eurartesim [online]. Available from URL: http://www.ema.europa.eu/docs/en-GB/document- library/EPAR-Sum mary-for-the-public/human/001199/WC500118117.pdf [Accessed 2012 Sep 11]
31. European Medicines Agency. Assessment report: pyramax [online]. Available from URL: http://www.ema.europa.eu/docs/en-GB/document-library/Other/2012/06/ WC500129290.pdf [Accessed 2012 Sep 11]
32. Areola S. Risk communication in Africa. World Library of Toxicology [online]. Available from URL: http://toxipedia. org/display/wlt/Africa [Accessed 2012 Sep 11]
33. Health Action International (HAI) Africa. Keep your hands off our medicines: health activists inKenya tell the European Union [online]. Available from URL: http://www.haiafrica. org/index.php?option=com-contentview=articleid= 153: keep-your-hands-off-our-medicines-health-activists-in-kenyatell-the- european-unioncatid=78:news [Accessed 2012 Sep 11]
34. Kotsimbos T, Waterer G, Jenkins C, et al. Influenza A/H1N1-09: Australia and New Zealand's winter of discontent. Am J Respir Crit Care Med [online]. Available fromURL: http://ajrccm.atsjournals.org/content/181/4/300. abstract [Accessed 2012 Sep 11]
35. Raising voices of discontent. China Daily 2012 May 30 [online]. Available from URL: http://www.china.org.cn/china/2012-05/30/content-25515448.htm [Accessed 2012 Sep 11]
36. Hyden G, Court J, Mease K. The bureaucracy and governance in 16 developing countries. Overseas Development Institute. World Governance Survey discussion paper 7 [online]. Available from URL: www.odi.org.uk/resources/docs/ 4104.pdf [Accessed 2012 Sep 11]
37. Jallow MK. African bureaucracy and the barriers to corruption II. The Gambia Echo 2007 Jan 12 [online]. Available from URL: http://www.thegambiaecho. com/Homepage/tabid/36/articleType/ArticleView/articleId/172/Default. aspx [Accessed 2012 Sep 11]
38. Mburu FM. Health delivery standards: vested interests in health planning. Soc Sci Med 1994 Nov; 39 (9): 1375-84
39. Bakke Ø, Endal D. Vested interests in addiction research and policy alcohol policies out of context: drinks industry supplanting government role in alcohol policies in sub-Saharan Africa. Addiction 2010 Jan; 105 (1): 22-8
40. Dodoo AN, Fogg C, Asiimwe A, et al. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy. Malar J 2009 Jan 5; 8: 2
41. McEwen J. Artesunate-and amodiaquine-associated extrapyramidal reactions: a series of 49 cases in VigiBase. Drug Saf 2012 Aug 1; 35 (8): 667-75
42. Nhlema Q. Bilharzia vaccination campaign stoppe das 1 boy dies, others faint [online]. Available from URL: http://www.capitalradiomalawi.com/index.php/ news-flash/367-bilharziavaccination-campaign-stopped-as-1-boy-dies-others- faintt [Accessed 2012 Sep 11]
43. H1N1 vaccine does not cause death-Dr Kunbuor [online]. Available from URL: http://www.ghanaweb.com/Ghana HomePage/NewsArchive/artikel.php?ID=187105 [Accessed 2012 Sep 11]
44. Centers for Disease Control and Prevention (CDC). Fatal poisoning among young children from diethylene glycolcontaminated acetaminophen: Nigeria, 2008-2009.MMWR Morb MortalWkly Rep 2009 Dec 11; 58 (48): 1345-7
45. Bakare N, Edwards IR, Stergachis A, et al. Global pharmacovigilance for antiretroviral drugs: overcoming contrasting priorities. PLoS Med 2011 Jul; 8 (7): e1001054
46. Kuemmerle A, Dodoo AN, Olsson S, et al. Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring. Malar J 2011 Mar 9; 10: 57
47. Vella S, Schwartlander B, Sow SP, et al. The history of antiretroviral therapy and of its implementation in resource-limited areas of the world. AIDS 2012 Jun 19; 26 (10): 1231-41
48. World Health Organization. UNAIDS, UNICEF: towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009. Geneva: World Health Organization, 2009
49. World Health Organization. Pharmacovigilance in public health programmes [online]. Available from URL: http://www.who.int/medicines/areas/quality-safety/ safety-efficacy/pharmpubhealth/en/index.html [Accessed 2012 Sep 11]
50. World Health Organization. Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents.Geneva: World Health Organization, 2009
51. Mateo MG, Gutierrez Mdel M, Vidal F, et al. Drug safety evaluation profile of stavudine plus lamivudine for HIV-1/AIDS infection. Expert Opin Drug Saf 2012 May; 11 (3): 473-85
52. Herná ndez Pérez E, Dawood H. Stavudine-induced hyperlactatemia/lactic acidosis at a tertiary communicable diseases clinic in South Africa. J Int Assoc Physicians AIDS Care (Chic) 2010 Mar-Apr; 9 (2): 109-12
53. Perazella MA. Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy. Kidney Int 2010 Dec; 78 (11): 1060-3
54. Riess H. MD Empathy in medicine: a neurobiological perspective. JAMA 2010 Oct 13; 304 (14): 1604-5
55. Sandman P. Empathy in risk communication [online]. Available from URL: http://www.psandman.com/col/empathy.htm [Accessed 2012 Sep 11]
56. Campbell RG, Babrow AS. The role of empathy in responses to persuasive risk communication: overcoming resistance to HIV prevention messages. Health Commun 2004; 16 (2): 159-82
57. Dunphy B, Dunphy S, Cantwell R, et al. Evidence basedpractice and affect: the impact of physician attitudes on outcomes associated with clinical reasoning and decisionmaking. Aust J Educ Dev Psychol 2010 ; 10: 56-64 [online]. Available from URL: http://www.eric.ed.gov/ERICWeb-Portal/search/detailmini. jsp?-nfpb=true-ERICExtSearch-SearchValue-0=EJ885707ERICExtSearch-SearchType-0= noaccno=EJ885707 [Accessed 2012 Sep 11]
58. Ojwang BO, Ogutu EA, Matu PM. Nurses' impoliteness as an impediment to patients' rights in selected Kenyan hospitals. Health Hum Rights 2010 Dec 15; 12 (2): 101-17
59. Atinga RA, Abekah-Nkrumah G, Domfeh KA. Managing healthcare quality in Ghana: a necessity of patient satisfaction. Int J Health Care Qual Assur 2011; 24 (7): 548-63
60. Asgary R, Grigoryan Z, Naderi R, et al. Lack of patient risk counselling and a broader provider training affect malaria control in remote Somalia Kenya border: qualitative assessment. Glob Public Health 2012; 7 (3): 240-52
61. Finlay A, Lancaster J, Holtz TH, et al. Patient-and providerlevel risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study. BMC Public Health 2012 Jan 20; 12: 56
62. Global Outbreak Alert and Response Network (GOARN) [online]. Available from URL: http://www.who.int/csr/out breaknetwork/en/[Accessed 2012 Sep 18]
63. Global Public Health Intelligence Network (GPHIN) [online]. Available from URL: http://www.who.int/csr/aler tresponse/epidemicintelligence/en/index. html [Accessed 2012 Sep 18]
64. Dodoo A. Healthy secrets: a layperson's guide to health issues. Accra: Creative Trends, 2011
65. Pal S, Dodoo A, Mantel A, et al. The world medicines situation 2011: pharmacovigilance and safety of medicines. Geneva: World Health Organization, 2011 [online]. Available from URL:WHO/EMP/MIE/2011.2.7 [Accessed 2012 Sep 12]